Invention Grant
- Patent Title: Human monoclonal antibody
- Patent Title (中): 人单克隆抗体
-
Application No.: US14603001Application Date: 2015-01-22
-
Publication No.: US09562105B2Publication Date: 2017-02-07
- Inventor: Takamasa Watanabe , Tadahiko Yoshima , Mikael Mattsson , Anna Sarnefalt , Takuya Hasezaki
- Applicant: Sumitomo Dainippon Pharma Co., Ltd.
- Applicant Address: JP Osaka
- Assignee: Sumitomo Dainippon Pharma Co., ltd.
- Current Assignee: Sumitomo Dainippon Pharma Co., ltd.
- Current Assignee Address: JP Osaka
- Agency: Leydig, Voit & Mayer, Ltd.
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28
Abstract:
The invention provides a method for the prophylaxis, improvement, or treatment of inflammatory bowel disease, multiple sclerosis, and psoriasis by administering to a subject an effective amount of an isolated anti-human CD81 antibody capable of binding to a peptide region consisting of the amino acid sequence of amino acid numbers 80 to 175 of SEQ ID NO:22.
Public/Granted literature
- US20150139990A1 HUMAN MONOCLONAL ANTIBODY Public/Granted day:2015-05-21
Information query
